ATCC is the premier global resource for authenticated biological materials and reference standards. ATCC has new tools for immunotherapy drug discovery, precision medicine, cutting-edge immuno-oncology reporter models, and our collection of advanced patient-derived organoid models developed in partnerships with the National Cancer Institute (NCI) / Human Cancer Models Initiative (HCMI) consortium.The focus of this presentation will be the innovative new oncology products being developed at ATCC, and how our authenticated, predictive, and biologically relevant oncology models can help accelerate your research.
Patient-Derived Organoid & Human Cancer Models Initiative
CAR-T Target Luciferase Reporter Cells
Checkpoint Luciferase Reporter Cells
ATCC Immune Cells
아래 링크를 클릭하시면 Full version abstract 및 더 자세한 내용을 확인 하실 수 있어요.